Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

ANIK — Anika Therapeutics, Inc.

EXPENSIVE (MOS Model unreliable) · Quality 55/100

Value Score 30 days ago: 10.6 → today 17.4

ANIK - Anika Therapeutics, Inc.
Data generated 2026-11-11 21:49 UTC (nightly scan, universe: Russell 3000).
Price: 13.95 USD
Intrinsic value: 4 USD
Margin of safety: Model unreliable
Implied growth (reverse DCF): +33.7% (model assumes +8.6%)
Valuation: EXPENSIVE
Value Score: 17.4
Quality: 55/100
Moat score: 6.2 (erosion: watch)
EXPENSIVE (MOS Model unreliable) - Quality 55/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/ANIK
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

13.95

Intrinsic value

Margin of safety

Model unreliable

Implied growth (reverse DCF)

+33.7%

model assumes +8.6%

Value Score

17.4

Quality

Psychology

Discovery

43.1

price/volume attention only

Moat score

6.2

erosion: watch

Value Score: bottom 29% of Russell 3000 · Quality: top 48%

Open the interactive Deep Dive for ANIK →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/ANIK - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is ANIK undervalued?

As of 2026-11-11, ANIK trades at 13.95 against a computed intrinsic value of 4 (-248.7% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Anika Therapeutics, Inc.'s Value Score?

Anika Therapeutics, Inc.'s Value Score is 17.4 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.